相似文献
1
[The consensus of the diagnosis and treatment of lymphoplasmacytic lymphoma/Walderström macroglobulinemia in China (2016 version)].
Zhonghua Xue Ye Xue Za Zhi. 2016 Sep 14;37(9):729-734. doi: 10.3760/cma.j.issn.0253-2727.2016.09.001.
2
t(1;14) and t(11;18) in the differential diagnosis of Waldenström's macroglobulinemia.
Mod Pathol. 2004 Sep;17(9):1150-4. doi: 10.1038/modpathol.3800164.
3
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2024 Jan;22(1D):e240001. doi: 10.6004/jnccn.2024.0001.
4
Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
J Med Case Rep. 2020 Jul 13;14(1):98. doi: 10.1186/s13256-020-02404-x.
5
Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Expert Rev Anticancer Ther. 2015;15(10):1143-56. doi: 10.1586/14737140.2015.1071668. Epub 2015 Jul 21.
6
Lymphoplasmacytic lymphoma infiltrating both lacrimal glands in a patient with Waldenström's macroglobulinemia.
Am J Ophthalmol Case Rep. 2020 Jan 15;17:100597. doi: 10.1016/j.ajoc.2020.100597. eCollection 2020 Mar.
7
L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.
PLoS One. 2013 Nov 5;8(11):e80088. doi: 10.1371/journal.pone.0080088. eCollection 2013.
8
Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
Indian J Pathol Microbiol. 2004 Oct;47(4):515-7.
9
Lymphoplasmacytic lymphoma-Waldenström macroglobulinemia: an unusual presentation in ovaries, fallopian tubes and uterine cervix.
Int J Clin Exp Med. 2013 May 22;6(5):346-50. Print 2013.
10
Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia.
Mod Pathol. 2009 Jun;22(6):807-16. doi: 10.1038/modpathol.2009.34. Epub 2009 Mar 13.
本文引用的文献
1
Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.
Blood. 2015 Sep 10;126(11):1392-4. doi: 10.1182/blood-2015-05-647420.
2
Ibrutinib in previously treated Waldenström's macroglobulinemia.
N Engl J Med. 2015 Apr 9;372(15):1430-40. doi: 10.1056/NEJMoa1501548.
3
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.
Blood. 2014 Aug 28;124(9):1404-11. doi: 10.1182/blood-2014-03-565135. Epub 2014 Jul 15.
4
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).
Blood. 2013 Nov 7;122(19):3276-82. doi: 10.1182/blood-2013-05-503862. Epub 2013 Sep 4.
5
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20.
6
Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
J Clin Oncol. 2013 Jan 20;31(3):301-7. doi: 10.1200/JCO.2012.44.7920. Epub 2012 Dec 10.
7
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.
8
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.
Cancer. 2012 Jan 15;118(2):434-43. doi: 10.1002/cncr.26303. Epub 2011 Jul 5.
9
Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen.
Br J Haematol. 2011 Aug;154(3):357-62. doi: 10.1111/j.1365-2141.2011.08750.x. Epub 2011 May 25.
10
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
Am J Hematol. 2010 Sep;85(9):670-4. doi: 10.1002/ajh.21788.
Zotero 插件